
April 2016: International Cross-Linking Experts Meeting Zurich December 2016
The ELZA member Farhad Hafezi is a member of the scientific committee and the co-organizer of the upcoming CXL Experts Meeting in Zurich on December 2-3, 2016.
The ELZA member Farhad Hafezi is a member of the scientific committee and the co-organizer of the upcoming CXL Experts Meeting in Zurich on December 2-3, 2016.
This clinical study by Alireza Peyman, with the participation of the ELZA members Farhad Hafezi and Sabine Kling, investigated whether the use of pulsed UV light would increase the biomechanical cross-linking effect, as suggested by others previously.
We are proud and very excited to announce that the Ocular Cell Biology and Keratoconus Research group of Prof. Farhad Hafezi moved from the University of Geneva to the CABMM (Center for Applied Biotechnology and Molecular Medicine) of the University of Zurich per January 1, 2016.
Zurich, Switzerland. A new study by the research group of Prof. Farhad Hafezi may open new alleys for the treatment of very thin keratoconic corneas in the future
The British journal “The Ophthalmologist” reports on our recent success in translating CXL technology into the mouse eye
New research from ELZA members opens up new alleys to study the molecular events underlying corneal cross-linking.
ELZA research shows that PACK-CXL can be accelerated from 30 minutes to 150 seconds only, while maintaining efficacy
Journal of the Royal Society Interface. Read here.
A major open issue when performing an excimer laser PRK after Cross-Linking is: how precise is the ablation in a cornea that had been cross-linked previously
ELZA members developed a new laboratory technique to measure corneal biomechanics before and after Cross-Linking
Stay informed & get the newsletter
You have successfully joined our subscriber list.
Newsletter abonnieren & informiert bleiben
Sie haben sich erfolgreich in unsere Abonnentenliste eingetragen.
Bitte bestätigen Sie Ihr Abonnement, indem Sie auf den Link in der E-Mail klicken, die wir Ihnen gerade geschickt haben.